Collaboration between academics and industry in clinical trials: cross sectional study of publications and survey of lead academic authors
Open Access
Abstract
Objectives: To determine the role of academic authors, funders, and contract research organisations in industry funded trials of vaccines, drugs, and devices and to determine lead academic authors’ experiences with industry funder collaborations. Design: Cross sectional analysis of trial publications and survey of lead academic authors. Eligibility criteria for selecting studies: The most recent 200 phase III and IV trials of vaccines, drugs, and devices with full industry funding, at least one academic author, published in one of the top seven high impact general medical journals ( New England Journal of Medicine , Lancet , JAMA , BMJ , Annals of Internal Medicine , JAMA Internal Medicine , and PLoS Medicine ). Results: Employees of industry funders co-authored 173 (87%) of publications; 183 (92%) trials reported involvement of funders in design, and 167 (84%) reported involvement of academic authors. Data analysis involved the funder in 146 (73%) trials and the academic authors in 79 (40%). Trial reporting involved the funder in 173 (87%) trials and academic authors in 197 (99%). Contract research organisations were involved in the reporting of 123 (62%) trials. Eighty (40%) of 200 lead academic authors responded to the survey. Twenty nine (33%) of the 80 responders reported that academics had final say on the design. Ten responders described involvement of an unnamed funder and/or contract research organisation employee in the data analysis and/or reporting. Most academic authors found the collaboration with industry funder beneficial, but 3 (4%) experienced delay in publication due to the industry funder and 9 (11%) reported disagreements with the industry funder, mostly concerning trial design and reporting. Conclusions: Industry employees and academic authors are involved in the design, conduct, and reporting of most industry funded trials in high impact journals. However, data analysis is often conducted without academic involvement. Academics view the collaboration as beneficial, but some report loss of academic freedom.Keywords
This publication has 29 references indexed in Scilit:
- Recommendations for a uniform assessment of publication bias related to funding sourceBMC Medical Research Methodology, 2013
- Sponsors’ participation in conduct and reporting of industry trials: a descriptive studyTrials, 2012
- Honorary and ghost authorship in high impact biomedical journals: a cross sectional surveyBMJ, 2011
- Improving academic leadership and oversight in large industry-sponsored clinical trials: the ARO-CRO modelBlood, 2011
- Investigator experiences with financial conflicts of interest in clinical trialsTrials, 2011
- Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialistsBMJ, 2011
- Effects of evidence-based clinical practice guidelines on quality of care: a systematic reviewQuality and Safety in Health Care, 2009
- Methods to increase response to postal and electronic questionnairesCochrane Database of Systematic Reviews, 2009
- Ghost Authorship in Industry-Initiated Randomised TrialsPLOS Medicine, 2007
- Academic Medical Centers' Standards for Clinical-Trial Agreements with IndustryNew England Journal of Medicine, 2005